Scott Mcclellan

Scott joined Orca Bio in 2018 and leads clinical development for the company. Scott has 13 years of research and development in the fields of oncology and malignant hematology. Prior to joining Orca, Scott was most recently a Medical Director at Genentech in early clinical development (oncology) where he led numerous clinical programs evaluating T cell-directing bispecific antibodies and antibody-drug conjugates for lymphoma and multiple myeloma. Prior to that, Scott was a Resident and Fellow in hematology and oncology at Stanford University School of Medicine. He later served as an Adjunct Clinical Assistant Professor of Medicine at Stanford, treating patients in the hematology clinic at the Palo Alto VA Hospital and performing research on acute lymphoblastic leukemia. Scott received a bachelor’s degree in biology from Birmingham-Southern College followed by an MD and a PhD in immunology from Washington University in St. Louis School of Medicine.